河络新图

Nanjing-based biotechnology company developing a cell therapy platform

Biotech & Life Sciences

Sector

Biotechnology platform developer

Model

01Company Overview

Nanjing-based biotechnology company developing a cell therapy platform.

02Backed By1 investor

03Recent Activity

Portfolio company Heluo Xintu closed a RMB 150M Pre-A round for its iPSC artificial-blood platform.

MILESTONE·mp.weixin.qq.com

AUG 2026

04Similar Companies

IB

AT

PT

PT

V

05Startup DNA

5

signals

Sectors
Business Model
Technology